Former CMS head: PBMs driving down drug costs, 'price-fixing' won't work

As the Trump Administration and new Congress signal their intent to somehow deal with the issue of rising prescription drug prices, the notion of giving the federal government more power to negotiate drug prices in Medicare Part D has been suggested as one measure that might be implemented. Two leading experts this week, however, threw cold water on that proposal, noting that such negotiations already exist and serve to bring down drug costs. Read More »